DIABETIC NEPHROPATHY

22
DIABETIC NEPHROPATHY PAA KWESI HACKMAN RD, LD, MSC DIETETICS, BSC NUTRITION AND FOOD SCIENCE 1

Transcript of DIABETIC NEPHROPATHY

Page 1: DIABETIC NEPHROPATHY

DIABETIC NEPHROPATHYPAA KWESI HACKMAN

RD, LD, MSC DIETETICS, BSC NUTRITION AND FOOD SCIENCE

1

Page 2: DIABETIC NEPHROPATHY

OutlineDEFINITIONEPIDEMIOLOGYRISK FACTORSPATHOPHYSIOLOGYSIGNS & SYMPTOMSCOMPLICATIONSMEDICAL DxMANAGEMENTMNTCONCLUSION

2

Page 3: DIABETIC NEPHROPATHY

DefinitionIt is a clinical syndrome characterized

by:• Persistent albuminuria (>300 mg/d or >200

μg/min) confirmed on at least 2 occasions 3-6 months apart.

• Progressive decline in GFR. • Elevated BP.

3

Page 4: DIABETIC NEPHROPATHY

Epidemiology382m (8.3%) adults with DM by 2013.

592m projected by 2035.Global mortality – 6%.

Almost a third of people with DM develop DN

DN 35-40% T1DM Pts. 15-20% T2DM Pts.Leading cause of ESRD. (6th IDF Atlas, 2013; ADA, 2007)

4

Page 5: DIABETIC NEPHROPATHY

Risk Factors

5

Page 8: DIABETIC NEPHROPATHY

S/SOedemaTroubled sleep or concentrationPoor appetiteNauseaWeakness Itching and extremely dry skinArrhythmia Muscle twitching

8

Page 9: DIABETIC NEPHROPATHY

ComplicationsHTNAnaemiaBone abnormalitiesCVDMalnutritionMetabolic acidosisUremiaHyperlipidaemia

9

Page 10: DIABETIC NEPHROPATHY

Medical Dx Blood tests

Urine tests• Dipstick• Alb:Cr ratio > 2.5 in males and > 3.5 in females is

abnormal.• Confirmed with AER of 20-200ug/min or 30-

300mg/24hrs & eGFR.

Imaging tests

Kidney biopsy (ADA, 2004) 10

Page 13: DIABETIC NEPHROPATHY

MNT Goals Achieve and maintain:

• BGL in the normal or safe.• Lipid profile that reduces CVD risk.• BP normal or safe.

To maintain good nutritional status, slow progression, and to treat complications.

To achieve weight loss in overweight or obese states.

To Enhance health through food choices and physical activity.

(ADA, 2008)

(ADA, 2008)

13

Page 14: DIABETIC NEPHROPATHY

MNT: Nutrition Assessment Anthro’s Biochemical Client Hx Diet Hx Nutrition-focused Physical findings

14

Page 15: DIABETIC NEPHROPATHY

MNT: Nutrition Dx /I

Inadequate energy intake Inappropriate intake of types of CHO Inadequate fibre intake Excessive mineral intake (Na+ or K+) Altered GI function (gastroparesis) Altered nutrition-related Lab values Food-medication interaction

15

Page 16: DIABETIC NEPHROPATHY

MNT: Nutrition Dx /IIFood-medication Interaction Underweight Food- and Nutrition-related Knowledge Deficit Not Ready For Diet/Lifestyle ChangeSelf-monitoring DeficitUndesirable Food ChoicesPhysical InactivityInability or Lack of Desire to Manage Self-care

16

Page 17: DIABETIC NEPHROPATHY

MNT: Intervention /I Nutritional education

Modified DASH Diet employed

Rx: CHO: 50-60% Protein: 10-20% Fat: < 30% (<10% Sats) Protein: 0.8 - 1g; 0.8g (in ESRD) & 1.2g/kg/d (dialysis)

Sodium: max = 2g/d

(NKF KDOQI, 2007; ADA, 2008)17

Page 18: DIABETIC NEPHROPATHY

MNT: Intervention /II To limit K+-rich foods in hyperkalemia

Fluid: 600-1000ml (severe oedema & dialysis)

Micronutrient supplementation may be necessary

Adequate PAL as tolerated

(NKF KDOQI, 2007; ADA, 2008)18

Page 19: DIABETIC NEPHROPATHY

MNT: M & E Weight

Intake

Labs

BP

Nutrition-focused physical findings

19

Page 20: DIABETIC NEPHROPATHY

Conclusion DN develops over a long duration. Timely screening is paramount. Aggressive mgt. of BGL, BP & Lipids helps in

preservation of renal function and can improve the outcome.

20

Page 21: DIABETIC NEPHROPATHY

References KDOQI Clinical Practice Guidelines and Clinical Practice

Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007;49(2 suppl 2):S12-S154.)

American Diabetes Association: Nephropathy in Diabetes (Position Statement). Diabetes Care 27 (Suppl.1): S79-S83, 2004

American Diabetes Association Standards of medical care in diabetes. Diabetes Care 30:S4-S36, 2007

American Diabetes Association Nutrition recommendations and interventions for diabetes. Diabetes Care 31:S61-S78, 2008

Hansen HP, Tauber-Lassen E, Jensen BR, et al. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int.2002;62(1):220-228.

IDF Atlas (2013). Pedrini MT, Levey AS, Lau J, et al. The effect of dietary protein

restriction on the progression of diabetic and nondiabetic renal diseases: meta-analysis. Ann Intern Med. 1996;124:627-632.

21